文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

体外膜氧合治疗脓毒性休克

Extracorporeal Membrane Oxygenation for Septic Shock.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论回顾性单中心研究显示,脓毒性休克接受体外膜氧合后医院存活率在左心室衰竭者达90%、分布性休克者达64.7%,长期总存活率59.5%。

该单中心高容量体外膜氧合中心的回顾性观察研究纳入2012至2017年37例脓毒性休克患者,均符合Sepsis-3标准且需血管活性正性肌力评分大于50才能维持平均动脉压大于65 mm Hg。27例接受静脉-动脉体外膜氧合、10例接受静脉-静脉体外膜氧合。左心室衰竭的脓毒性休克患者医院存活率为90%,分布性休克患者为64.7%;46.1个月长期随访总存活率为59.5%。开始静脉-静脉体外膜氧合及入院时器官衰竭更多与较差的医院和长期存活相关。

要点

  • 纳入标准为Sepsis-3脓毒性休克且需血管活性正性肌力评分大于50才能维持平均动脉压大于65 mm Hg,尽管已充分液体复苏。
  • 37例中27例接受静脉-动脉体外膜氧合、10例接受静脉-静脉体外膜氧合,左心室衰竭者医院存活率90%,分布性休克者64.7%。
  • 46.1个月长期随访总存活率为59.5%。
  • 开始静脉-静脉体外膜氧合及入院时器官衰竭更多与较差的医院和长期存活相关。

适用人群与场景

  • 2012至2017年在单中心高容量体外膜氧合中心因脓毒性休克治疗、年龄大于18岁、接受体外膜氧合时符合Sepsis-3脓毒性休克标准者。
  • 存在心循环衰竭,需相当于血管活性正性肌力评分大于50的支持才能达到平均动脉压大于65 mm Hg,尽管已充分液体复苏。

诊断标准与关键阈值

  • 接受体外膜氧合时符合Sepsis-3脓毒性休克标准。
  • 心循环衰竭需相当于血管活性正性肌力评分大于50的支持才能达到平均动脉压大于65 mm Hg,尽管已充分液体复苏。

研究设计与关键结果

  • 回顾性观察研究,单中心,纳入37例,平均年龄54.7岁,简化急性生理学评分-3中位数86,序贯器官衰竭评估中位数16。
  • 27例接受静脉-动脉体外膜氧合,10例接受静脉-静脉体外膜氧合。
  • 左心室衰竭的脓毒性休克医院存活率90%,分布性休克患者医院存活率64.7%。
  • 46.1个月长期随访总存活率59.5%。
  • 开始静脉-静脉体外膜氧合及入院时器官衰竭更多与较差的医院和长期存活相关。

证据类型、等级与局限

  • 证据类型:回顾性观察研究,单中心。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,当前结果不仅增加了静脉-动脉体外膜氧合对脓毒性心肌病有益的日益增多的证据,也提示分布性脓毒性休克患者医院存活率改善。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Septic shock carries a high mortality risk. Studies have indicated that patients with septic shock may benefit from extracorporeal membrane oxygenation. In most studies, patients exhibited shock due to myocardial dysfunction rather than distributive/vasoplegic shock. One proposed theory is that venoarterial extracorporeal membrane oxygenation alleviates a failing myocardial function.

DESIGN: Retrospective observational study.

SETTING: Single-center, high-volume extracorporeal membrane oxygenation unit.

PATIENTS: All patients treated for septic shock between 2012 and 2017 with an age greater than 18 years old, fulfilling septic shock criteria according to "Sepsis-3" at acceptance for extracorporeal membrane oxygenation, presence of cardiocirculatory failure requiring a support equivalent to a Vasoactive Inotropic Score greater than 50 to reach a mean arterial pressure greater than 65 mm Hg despite adequate fluid resuscitation, were included.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Thirty-seven patients, mean age 54.7 years old, were included. Median Simplified Acute Physiology Score-3 score was 86 and Sequential Organ Failure Assessment 16. Twenty-seven patients were submitted to venoarterial and 10 patients to venovenous extracorporeal membrane oxygenation. Hospital survival was 90% for septic shock with left ventricular failure and 64.7% in patients with distributive shock. At long-term follow-up at 46.1 months, total survival was 59.5%. Commencement of venovenous extracorporeal membrane oxygenation and more organ failures at admission showed a less favorable outcome in terms of hospital and long-term survival.

CONCLUSIONS: The current results add not only to the growing evidence of the benefit of venoarterial extracorporeal membrane oxygenation for septic cardiomyopathy but also indicate improved hospital survival in distributive septic shock.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Falk L, Hultman J, Broman LM, et al. Extracorporeal Membrane Oxygenation for Septic Shock. Crit Care Med. 2019. PMID: 31162206. doi:10.1097/CCM.0000000000003819

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。